Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Change in Receivables (2020 - 2025)

Celularity has reported Change in Receivables over the past 6 years, most recently at -$4.5 million for Q3 2025.

  • Quarterly results put Change in Receivables at -$4.5 million for Q3 2025, up 5.04% from a year ago — trailing twelve months through Sep 2025 was -$2.0 million (down 135.03% YoY), and the annual figure for FY2024 was $4.0 million, down 41.88%.
  • Change in Receivables for Q3 2025 was -$4.5 million at Celularity, down from -$3.8 million in the prior quarter.
  • Over the last five years, Change in Receivables for CELU hit a ceiling of $6.7 million in Q4 2023 and a floor of -$4.8 million in Q3 2024.
  • Median Change in Receivables over the past 5 years was $844000.0 (2021), compared with a mean of $488684.2.
  • Biggest five-year swings in Change in Receivables: surged 717.65% in 2021 and later tumbled 1883.33% in 2025.
  • Celularity's Change in Receivables stood at $1.2 million in 2021, then decreased by 22.42% to $896000.0 in 2022, then skyrocketed by 648.77% to $6.7 million in 2023, then decreased by 25.15% to $5.0 million in 2024, then plummeted by 190.5% to -$4.5 million in 2025.
  • The last three reported values for Change in Receivables were -$4.5 million (Q3 2025), -$3.8 million (Q2 2025), and $1.3 million (Q1 2025) per Business Quant data.